Trial intelligence / Profile preview

Pharmacokinetic Similarity Between KM04, US-Gonal-f, and EU-Gonal-f in Healthy Female Volunteers

NCT07794683Phase 1Not yet recruiting

Sponsor
Xentria
Start
Nov 2026
Primary completion
May 2027
01

Overview

Phase 1, randomised, double-blind trial of KM04 in infertility (3 arms), sponsored by Xentria. Primary endpoints: Maximum observed serum concentration and Area under the concentration-time curve from time 0 to the last quantifiable concentration. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

KM04
03

Conditions

infertility

Beyond the preview

Go deeper on NCT07794683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07794683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call